Brief: Gilead Sciences Reports 9.6% Passive Stake In Kyverna Therapeutics As Of Feb 12, 2024
Feb 20 (Reuters) - Gilead Sciences Inc GILD.O :
* GILEAD SCIENCES, INC. REPORTS 9.6% PASSIVE STAKE IN
KYVERNA
THERAPEUTICS INC AS OF FEBRUARY 12, 2024- SEC FILING
Source text for Eikon: ID:n0001193125-24-040028
Further company coverage: GILD.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Kyverna Therapeutics
See all newsHealth Rounds: Appendix removal linked with lower colon cancer risk in study
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
U.S. STOCKS ON THE MOVE-Everpure, Dropbox, Darden Restaurants